BFI Finance Indonesia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? BFI Finance Indonesia Tbk trades at Rp915 (market cap 13.76T, 29.96M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 29.2× Prodia Diagnostic Line Tbk's market cap, and BFI Finance Indonesia Tbk is more actively traded (29.96M versus 28.43M). Which is the better fit depends on your goals.
| BFIN | PRDL | |
|---|---|---|
Market Cap | 13.76T | 470.58B |
Volume | 29.96M | 28.43M |
Lot | 299.63K | 284.34K |
Turnover | 27.08B | 7.8B |
Average Price | 903.88 | 274.19 |
Value | 27.08B | 7.8B |
Indicative Equilibrium Price | 915 | 270 |
Indicative Equilibrium Volume | 2.26K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →